Tentarix Biotherapeutics has filed a notice of an exempt offering of securities to raise $34,999,997.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Tentarix Biotherapeutics is raising $34,999,997.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Paul Grayson played a…